Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Rose and valerian tablet and Omeprazole capsule on adult reflux symptoms
IRCT20161031030616N4Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of omeprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Golestan University of Medical Sciences. Primary endpoint: Improvement in adult reflux symptoms. Started Jun 2025; status: completed.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on IRCT20161031030616N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161031030616N4.